Irina Antonijevic

Irina Antonijevic

Company: Triplet Therapeutics

Job title: Chief Medical Officer


Live Panel Q&A – Ask the Speakers your Burning Questions! 10:45 am

Read more

day: Day Two

Targeting DNA Damage Response Genes with Oligonucleotides for Therapeutic Modulation of Somatic Instability in the Brain 9:55 am

Discussing how genes in the DNA damage response (“DDR”) pathway are potent genetic modifiers of Repeat Expansion Disorders (REDs), such as Huntington disease (HD), myotonic dystrophy, spinocerebellar ataxias, and operate upstream of disease genes Outlining how Triplet targets this fundamental unifying pathway with the goal to slow somatic repeat expansion and potentially delay or prevent…Read more

day: Day Two

PANEL DISCUSSION: From Theory to Reality: How to Target the Central Nervous System with RNAi Based Therapies 2:05 pm

In the past few years, RNAi therapeutics have rocketed as a widely promising potential therapy for several diseases. With the major shift of interest to target the central nervous system, it is critical to now consider the viability of targeting the CNS for therapeutic intervention and debate the important next steps to ensure RNAi CNS…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.